1-6 of 6
H. Yang
Close
Sort by
Journal Articles

Outcomes of Catheter-Based Therapy for Cancer-Associated Intermediate or High-Risk Pulmonary Embolism

Orly Leiva, Eric H Yang, Rachel P. Rosovsky, Carlos Alviar, Sripal Bangalore
Journal: Blood
Blood (2023) 142 (Supplement 1): 2361.
https://doi.org/10.1182/blood-2023-187947
Published: 2023
Journal Articles

Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple Myeloma

James R. Berenson, Daisy Martinez, Tahmineh Safaie, Ralph Boccia, Honghao H Yang, Mehdi M. Moezi, Stephen Lim, Gary Edward Schwartz, Shahrooz Eshaghian, Regina Swift, Benjamin Eades, Sean Elliott Bujarski, Bernard Sean Regidor, Clara Kim, Susanna Kim, Robert Vescio
Journal: Blood
Blood (2022) 140 (Supplement 1): 12610–12611.
https://doi.org/10.1182/blood-2022-163872
Published: 2022
Journal Articles

Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma

James R. Berenson, Daisy Martinez, Tahmineh Safaie, Noemi Silagan, Jennifer To, Tanya M. Spektor, Eli Forouzan, Regina Swift, Benjamin Eades, Shahrooz Eshaghian, Gary Schwartz, Ralph V. Boccia, Honghao H Yang, Mehdi M. Moezi, Stephen Lim, Robert Vescio
Journal: Blood
Blood (2021) 138 (Supplement 1): 2727.
https://doi.org/10.1182/blood-2021-151016
Published: 2021
Journal Articles

Characterizing Cardiovascular Outcomes Following Chimeric Antigen Receptor T Cell Therapy: A Single Institution, Retrospective Analysis

Michael V Rothberg, Patrick Holman, MD, Daria Gaut, MD, Tomas G Nielan, MD MPH, Syed S Mahmood, MD MPH, Eric H Yang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-137783
Published: 2020
Journal Articles

Bortezomib in Combination with Melphalan in the Treatment of Relapsed or Refractory Multiple Myeloma: A Phase I/II Study.

James Berenson, MD, H. Yang, R. Swift, K. Sadler, R. Vescio, J. Adams, D. Schenkein
Journal: Blood
Blood (2004) 104 (11): 209.
https://doi.org/10.1182/blood.V104.11.209.209
Published: 2004
Journal Articles

A Novel Triple Purge Strategy for Eliminating Chronic Myelogenous Leukemia (CML) Cells from Autografts.

H. Yang, C. Eaves, M. de Lima, M. Lee, R. Champlin, J. McMannis, S. Robinson, T. Niu, W. Decker, D. Xing, M. Thomas, J. Ng, S. Li, A. Eaves, R. Jones, B. Andersson, E. Shpall
Journal: Blood
Blood (2004) 104 (11): 152.
https://doi.org/10.1182/blood.V104.11.152.152
Published: 2004